These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9854674)

  • 1. Con: heparin-bonded cardiopulmonary bypass circuits do not represent a desirable and cost-effective advance in cardiopulmonary bypass technology.
    Woolf RL; Mythen MG
    J Cardiothorac Vasc Anesth; 1998 Dec; 12(6):710-2. PubMed ID: 9854674
    [No Abstract]   [Full Text] [Related]  

  • 2. Pro and con of heparin-bonded circuits for cardiopulmonary bypass.
    Weiss BM; von Segesser LK
    J Cardiothorac Vasc Anesth; 1999 Oct; 13(5):646-52. PubMed ID: 10527241
    [No Abstract]   [Full Text] [Related]  

  • 3. Pro: heparin-bonded circuits represent a desirable option for cardiopulmonary bypass.
    Shore-Lesserson L
    J Cardiothorac Vasc Anesth; 1998 Dec; 12(6):705-9. PubMed ID: 9854673
    [No Abstract]   [Full Text] [Related]  

  • 4. Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit?
    Mahmood S; Bilal H; Zaman M; Tang A
    Interact Cardiovasc Thorac Surg; 2012 Apr; 14(4):406-14. PubMed ID: 22228288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Con: Heparin-bonded cardiopulmonary bypass circuits should be routine for all cardiac surgical procedures.
    Taneja R; Cheng DC
    Anesth Analg; 2006 Dec; 103(6):1370-2. PubMed ID: 17122205
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits.
    Aldea GS; O'Gara P; Shapira OM; Treanor P; Osman A; Patalis E; Arkin C; Diamond R; Babikian V; Lazar HL; Shemin RJ
    Ann Thorac Surg; 1998 Feb; 65(2):425-33. PubMed ID: 9485240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin generation with heparin-bonded cardiopulmonary bypass circuits.
    Bannan S; Martin PG
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):849. PubMed ID: 8800182
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting.
    Øvrum E; Tangen G; Tølløfsrud S; Skeie B; Ringdal MA; Istad R; Øystese R
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1145-9. PubMed ID: 20709334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reoperative sternotomy: minimizing injury without the risks of systemic heparin.
    Singh AK; Stearns G; Maslow A; Feng WC; Schwartz C
    J Thorac Cardiovasc Surg; 2011 Apr; 141(4):1085; author reply 1085. PubMed ID: 21419908
    [No Abstract]   [Full Text] [Related]  

  • 10. Low heparinization and heparin-bonded circuits.
    Hill RC
    Ann Thorac Surg; 1997 Oct; 64(4):1221-2. PubMed ID: 9354574
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving cardiopulmonary bypass: heparin-coated circuits.
    Vocelka C; Lindley G
    J Extra Corpor Technol; 2003 Dec; 35(4):312-6. PubMed ID: 14979422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low heparinization with heparin-bonded bypass circuits: is it a safe strategy?
    Bannan S; Danby A; Cowan D; Ashraf S; Martin PG
    Ann Thorac Surg; 1997 Mar; 63(3):663-8. PubMed ID: 9066381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke from heparin-coated circuits and reduced systemic anticoagulation.
    Dewanjee MK
    Ann Thorac Surg; 1997 Oct; 64(4):1218-9. PubMed ID: 9354569
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin-coated bypass circuits in cardiopulmonary bypass: improved biocompatibility or not.
    Levy M; Hartman AR
    Int J Cardiol; 1996 Apr; 53 Suppl():S81-7. PubMed ID: 8793597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass.
    de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C
    Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro: Heparin-coated circuits should be used for cardiopulmonary bypass.
    Jessen ME
    Anesth Analg; 2006 Dec; 103(6):1365-9. PubMed ID: 17122204
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of Heparin-Resistant Patients with Benefits? Maximizing Biocompatibility in Cardiopulmonary Bypass: Combining ATryn® Recombinant Antithrombin III and Carmeda® Heparin-Bonded Perfusion Circuits: A Case Series.
    Chryssos A; Stroup SJ; Pifer MM; Tawil M; Conrad CG
    J Extra Corpor Technol; 2015 Mar; 47(1):44-7. PubMed ID: 26390679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-bonded circuits: clinical outcomes and costs.
    Mahoney CB
    Perfusion; 1998 May; 13(3):192-204. PubMed ID: 9638717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.